Profile
Shoshana Shendelman was the founder of Clearpoint Strategy Group LLC, founded in 2012, serving as Managing Director from 2012 to 2016.
Dr. Shendelman was the founder of Applied Therapeutics, Inc., founded in 2016, serving as Chairman, President & Chief Executive Officer.
Dr. Shendelman is also the founder of Cyana Therapeutics LLC..
Dr. Shendelman was Director at KBL Merger Corp.
IV.
Dr. Shendelman was Director at ETHZilla Corp.
Dr. Shendelman completed undergraduate studies at Brandeis University.
Dr. Shendelman earned a doctorate from Columbia University College of Physicians & Surgeons.
Shoshana Shendelman active positions
| Companies | Position | Start |
|---|
Former positions of Shoshana Shendelman
| Companies | Position | End |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Chief Executive Officer | 19/12/2024 |
| FORUM MARKETS, INCORPORATED | Director/Board Member | 17/12/2020 |
Clearpoint Strategy Group LLC | Founder | 01/12/2016 |
| KBL MERGER CORP. IV | Director/Board Member | - |
Training of Shoshana Shendelman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Applied Therapeutics, Inc.
Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
KBL Merger Corp. IV
KBL Merger Corp. IV Financial ConglomeratesFinance Operates as blank check company | Finance |
Clearpoint Strategy Group LLC | |
180 Life Sciences Corp.
180 Life Sciences Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for chronic pain and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Shoshana Shendelman
















